Other News To Note
Wednesday, August 22, 2012
NPS Pharmaceuticals Inc., of Bedminster, N.J., said it was notified by the FDA that its new drug application for Gattex (teduglutide) will be discussed at the meeting of the Gastrointestinal Drugs Advisory Committee on Oct. 16.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.